LC-ESI-MS/MS techniques for Method Development and Validation for Estimation of Propofol In plasma matrix
DOI:
https://doi.org/10.22270/ijmspr.v8i3.49Keywords:
SPE, LLE, Quality control samples, Bioequivalence, Bioavailability, ValidationAbstract
A compound can often be measured by several methods and the choice of analytical method involves many considerations. Analysis of drugs and their metabolites in a biological matrix is carried out using different extraction techniques like liquid- liquid extraction, solid phase extraction (SPE) and protein precipitation from these extraction methods samples are spiked with calibration (reference) standards and using quality control (QC) samples. These methods and choice of analytical method describes the process of method development and includes sampling, sample preparation, separation, detection and evaluation of the results. The developed process is then validated. These Bioanalytical validations play a significant role in evaluation and interpretation of bioavailability, bioequivalence, pharmacokinetic, and toxicokinetic studies. In which different parameters like accuracy, precision, selectivity, sensitivity, reproducibility, and stability are performed.
Keywords: - LLE, SPE, Quality control samples, Bioequivalence, Bioavailability, Validation.
References
Ahuja S and Rasmussen HT, HPLC Method Development for Pharmaceuticals, Academic Press, 2007, pp. 485-489.
Sharma BK, Industrial methods of chemical analysis, 20th edition, GOEL publishing house, 2005, 68-80, 114-165, pp. 286-320.
Basics of LC/MS, Primer, Agilent Technologies, Innovating the HP Way, pp. 1- 36.
Buick AR, Doig MV, Jeal SC, Land GS and McDowall RD, "Method Validation in the Bio-analytical Laboratory", Journal of Pharmaceutical and Biomedical Analysis, 1990; 8: pp 629-637. https://doi.org/10.1016/0731-7085(90)80093-5
Shah VP, Midha KK, Dighe SV, Analytical Method Validation: Bioavailability, Bioequivalence and Pharmacokinetic studies. Pharmaceutical Research 1992; 9:588-592. https://doi.org/10.1023/A:1015829422034
Dabhi MJ, Bio-analytical Method Development and its Validation, 2009.
Indian Pharmacopoeia, Government of India, Ministry of Health & Family Welfare, Indian Pharmacopoeia commission, Ghaziabad, 2014, vol.-III, 2576 - 2577.
British Pharmacopoeia-2016, British pharmacopoeia commission, Volume II Ph Eur monograph 1558(for Propofol) 691.
USP-34/NF29 2011, volume II, Asian Ed., United state Pharmacopoeial Convention, Inc., Rockville, MD, 4046 - 4049.
Vaiano F., Serpelloni G., Focardi M., Fioravanti A., Mari F., Bertol E., "LC- MS/MS and GC-MS methods in propofol detection: Evaluation of the two analytical procedures", Journal of Pharmaceutical and Biomedical Analysis 39, 2005, 1-6 https://doi.org/10.1016/j.forsciint.2015.07.013
Leea S.Y., Parka N., Jeonga E., Wia J., Kimb C., Kim J.Y., Kyo Inc M., Honga J.; "Comparison of GC/MS and LC/MS methods for the analysis of propofol and its metabolites in urine", Journal of Chromatography B 2012; 900:1- 10 https://doi.org/10.1016/j.jchromb.2012.05.011
Alvarez J.C., Abe E., Etting I., GuenM.L., Devillier P., Grassin-Delyle S., "Quantification of remifentanil and propofol in human plasma: a LC-MS/MS assay validated according to the EMA guideline", Bioanalysis, 2015, 1675-168 https://doi.org/10.4155/bio.15.89
Hamd M., Wada M., Ikeda R., Kawakami S., Nakashima K.; "Validation of an LC-MS/MS Method for the Determination of Propofol, Midazolam, and Carbamazepine in Rat Plasma: Application to Monitor Their Concentrations Following Co-administration", The Pharmaceutical Society of Japan, 2015; 30(8):1250-1253 https://doi.org/10.1248/bpb.b15-00191
Pyo J.S.; "Selective and Accurate Determination Method of Propofol in Human Plasma by Mixed-Mode Cation Exchange Cartridge and GC-MS", Journal of analytical methods in chemistry, 2016, 1-6. https://doi.org/10.1155/2016/9531769
Ranshang zhang. Propofol Composition and methods of treating chronic pain by administering Propofol derivative United states patent, US8546453 B2, 2013
Wilson, Louis j., Dale B., James N. Apparatus and method for modelling and predicting sedative effect of drug such as Propofol on patients, International Patent, US2014/059829, 2014
Diaone N. Thompson, Gerold L. Mosher. Formulations containing Propofol and a sulfoalkyl ether cyclodextrin, United states patent, US7034013B2, 2006
Bosteels, Arnaud. Combination of Remifentanyl and Propofol, International Patent, PCT/EP2015/080788, 2016
Published
How to Cite
Issue
Section
Copyright (c) 2022 Sourabh Mittal, Neetesh Kumar Jain, Sourabh Billore, Riddhi Bajapai
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.